Clinical Trials Browser

OTHER × Acquired Immunodeficiency Syndrome × 90 days × Clear all

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04150120 2026-04-06

eChildHealth

Congenital Abnormalities, Acquired Immunodeficiency Syndrome, Heart Defects, Congenital, Hirschsprung Disease, Neoplasms, Patient Compliance, Child Nutrition Disorders, Premature Birth

NCT05935644 2026-03-19

ORCHID-Miami

Phase NA Enrolling by invitation

30 enrolled

Acquired Immunodeficiency Syndrome, Depression, Papillomavirus Infections

NCT07468695 2026-03-12

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya

Phase NA Not yet recruiting

300 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

NCT07209917 2026-02-23

ASHA-Health II

Phase NA Recruiting

420 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms, Infections, Papillomavirus Infections

NCT05413811 2026-02-17

ACT2

Phase NA Completed

180 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms

NCT07390916 2026-02-05

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS5 Rwanda

Phase NA Not yet recruiting

300 enrolled

Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia

Clinical Trials

CASCADE3002

eChildHealth

ORCHID-Miami

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya

ASHA-Health II

ACT2

Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS5 Rwanda